SpayVac

SpayVac is a biotechnology company specializing in innovative, breeding control using an injectable birth control vaccine. Using their proprietary vaccine nanoparticle platform, SpayVac provides single-dose, long-term fertility control for production animals, such as swine, farm-raised fish, companion animals, and various feral and wild species. Their technology leverages immunocontraception. The nanoparticle delivery platform creates a robust and efficient immune response reducing the need for booster vaccines

  • About their product/solution: Proprietary liposomal technology for single-dose vaccines
  • No. of employees: 6
  • HQ: Madison, Wisconsin, USA
  • Founded in: 2019
  • Raised so far: $1.25M
  • Backed by: Angel investors
  • Looking to engage with: Potential partners and investors.
Loading